Level of HER2/neu gene amplification as a predictive factor of response to trastuzumab-based therapy in patients with HER2-positive metastatic breast cancer
Giuseppe Gullo, Daniela Bettio, Valter Torri, Giovanna Masci, Piermario Salvini, Armando SantoroVolume:
27
Language:
english
Pages:
5
DOI:
10.1007/s10637-008-9155-y
Date:
April, 2009
File:
PDF, 139 KB
english, 2009